(22) demonstrated that L-arginine mitigates inflammation-induced bone loss in arthritis, while ADA inhibitors abolished the suppressive effect of L-arginine on osteoclastogenesis in both in vitro and in vivo models. This evidence concerns the gene ADA and arthritic joint disease.